An Epidemic of Adenovirus 7a Infection in a Neonatal Nursery: Course, Morbidity, and Management

Infection Control & Hospital Epidemiology

Volumn 9, Issue 9, 1988, Pages 398-404

  Finn, Adam ^b   Anday, Endla ^a   Talbot, George H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROSS INFECTION; ECONOMICS; EPIDEMIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INFANT; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NURSERY; PRESCHOOL CHILD; PROTECTIVE CLOTHING; VIRUS INFECTION;

ADENOVIRIDAE INFECTIONS; ADENOVIRUS INFECTIONS, HUMAN; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; NURSERIES, HOSPITAL; PROTECTIVE CLOTHING;

EID: 0024075007     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1086/645898     Document Type: Article

References (20)

1. Spencer MJ., Cherry JD., in Feigin RD Cherty JD (eds): Textbook of Pediatric Infectious Diseases, ed 2. Philadelphia, WB Saunders Co, 1987, pp 1688–1701.
2. Herbert FA. Wilkinson D., Burchak E. et al: Adenovirus type 3 pneumonia causing lung damage in childhood. Can Med Assoc J. 1977; 110:274–276.
3. Angella JJ., Connor JD: Neonatal infection caused by adenovirus type 7. J. Pediatr. 1968; 72:474–478.
4. Zahradnik JM, Spencer MJ, Porter DD: Adenovirus infection in the immunocompromised patient. Am J Med 1980; 68:725–732.
5. Straube RC. Thompson MA, Van Dyke RB, et al: Adenovirus type 7b in a children's hospital. J. Infect Dis. 1983: 147:814–819.
6. Alpert G., Charney F., Fee M., et al: Outbreak of fatal adenoviral type 7a respiratory disease in a children's long–term care inpatient facility. Am J Infect Control 1986; 14:188–190.
7. Eichenwald HF, Kotsevalov O: Immunologic responses of premature and fullterm infants to infection with certain viruses. Pediatrics 1960; 25:829–839.
8. St. Geme JW, Prince JT: Mixed systemic virus infection: A postulate for alteration of host resistance to adenovirus infection. J Pediatr 1966; 69:653–655.
9. Odio C, McCracken GH, Nelson JD: Disseminated adenovirus infection: A case report and review of the literature. Pediatr Infect Dis 1984; 3:46–49.
10. Levandowski RA. Rubenis M: Nosocomial conjunctivitis caused by adenovirus type 4. J Infect Dis 1981: 143:28–31.
11. Pingleton SK, Pingleton WW, Hill RH. et al: Type 3 adenoviral pneumonia occurring in a respiratory intensive care unit. Chest 1978: 73:554–555.
12. Larsen RA. Jacobson JT, Jacobson JA, et al: Hospital–associated epidemic of pharyngitis and conjunctivitis caused by adenovirus (21/1121 + 35). J Infect Dis 1986: 154:706–709.
13. Faden H, Gallagher M. Ogra P, et al: Nosocomial outbreak of pharyngoconjunctival lever due to adenovirus type 4–New York. MMWH 1978; 27:49.
14. Barr J. Kjellen L, Svedmyr A: Hospital outbreak of adenovirus type 3 infections. A clinical and virologic: sludv on 38 patients partly involved in a nosocomial outbreak. Acta Paediatr (suppl) 1958; 47:365–382.
15. Harrison HR. Howe P. Minnich L, et al: A cluster of adenovirus 19 infection with multiple clinical manifestations. J Pediatr 1979; 94:917–919.
16. Chany C, Lepine P, Lelong M, et al: Severe and latal pneumonia in infants and young children associated with adenovirus itfections. Am J Hyg 1958: 67:367–378.
17. Hierliolzer JC. Phillips DJ., Humphrey DD., et al: Application of a solid–phase immunoHuorometric: assay to the selection of monoclonal antibody specific for the adenovirus group–reactive hexon antigen. Arch Viral 1969: 80:1–10.
18. Friedman HM, Koropchak C: Comparison of W1–38. MRC–5.and I MR–90 cell strains for isolation of viruses from clinical specimens. J. Clin Microbiol 1978; 7:368–371.
19. Couch RB, Cate TR, Fleet WF, et al: Aerosol–induced adenoviral illness resembling the naturally occurring illness in military rec ruits. Am Rev Re.cpir fin Dis 1966; 93:529–535.
20. Gala CL, Hall CB. Schnabel KC, et al: the use of eve–nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 1986: 256:2706–2708.